Peter Grogg (1942) Dr. h.c., Chairman, Swiss
since 1971, elected until 2012

Peter Grogg founded Bachem AG in 1971 and was the CEO until 2002. From 1967 to 1971, he was one of the owners of Fox Chemical Corporation. He is Chairman of the Board of Directors of Pevion Biotech and of Ingro Finanz AG. He is member of the Board of Directors of Polyphor AG, Dottikon ES Holding AG and Tillotts Pharma AG

Gottlieb Knoch (1942) Graduate Chemist ETH, MBA, Vice-Chairman, Swiss
since 1985, elected until 2012

Gottlieb Knoch holds a diploma of chemistry of ETH Zurich and an MBA of Stanford University. Among other assignments he worked for McKinsey & Co in Zurich, Saurer AG in Arbon and Tecan AG in Männedorf. In addition, he has assumed the function of a "business angel" helping innovative start-ups with advice and support. Board member of Rothschild Bank AG

Thomas Burckhardt (1950) Dr. iur., LL.M., Secretary of the Board, Swiss
since 1997, elected until 2012

Thomas Burckhardt studied at the Universities of Basel, Geneva and Munich and was awarded his doctorate in 1978 in Basel. Since 1975 he is licensed attorney and in 1979 received a Master of Law (LL.M.) at Harvard Law School (Cambridge, Massachusetts, US). Since 1980 he practices as lawyer in Zurich and Basel and since 1987 is an associate at Simonius Pfrommer & Partner. Thomas Burckhardt further is Honorary Consul-General of the Kingdom of Thailand in Basel as well as president of an important charity in favour of young and disabled persons in Basel. Other important board memberships: CMA CGM Agency AG, Viking River Cruises AG

Hans Hengartner (1944) Prof. Dr. sc. nat. ETH, Member, Swiss
since 2003, elected until 2012

Hans Hengartner studied biochemistry and molecular biology at ETH Zurich and holds a doctorate in natural sciences from ETH Zurich. He is currently Co-Director of the Institute for Experimental Immunology at the University Hospital of Zurich. He is also ordinary professor for immunology at the medical faculty of the University of Zurich and at the Department of biology of ETH Zurich. From 2000 to 2005 Hans Hengartner was in charge of the department of biology at ETH Zurich.

Jürgen Brokatzky-Geiger (1952) Ph.D. in chemistry, Member, German
since 2009, elected until 2012

Dr. Jürgen Brokatzky-Geiger (born 1952) graduated with a Ph.D. in chemistry from the University of Freiburg, Germany, in 1982. He joined Ciba-Geigy Ltd. in 1983 as a Laboratory Head in the Pharmaceuticals Division. After a job rotation in the United States, he held positions of increasing responsibility in Research and Development (R&D) including Group Leader of Process R&D, Head of Process R&D, and Head of Process Development and Pilot Plant Operations.
During the merger of Ciba-Geigy and Sandoz in 1996, Dr. Jürgen Brokatzky-Geiger was appointed Integration Officer of Technical Operations. He later became the Head of Chemical and Analytical Development and served as the Global Head of Technical R&D from 1999 to August 2003. Dr. Jürgen Brokatzky-Geiger was appointed to his present position as Head of Human Resources on September 1, 2003. He has been a member of the Executive Committee of Novartis since January 1, 2005.

Corporate Executive Committee

Rolf Nyfeler (1950) Dr. phil. II, CEO, Swiss
since 2000

Rolf Nyfeler joined Bachem in 1982. He was responsible for Research and Development for some time and became COO of the Parent Company in 1998, after a commitment as Head of Production in the subsidiary in California. Since May 1, 2002, he is CEO of the Bachem Group and Chairman of the Corporate Executive Committee. He completed his education as a chemist at the Universities of Basel and San Diego and at the Max-Planck-Institute in Martinsried. Rolf Nyfeler is member of the management board of the Swiss Association of the Chemical Induestry (SGCI).

Stephan Schindler (1964) business economist HWV, cand. MBA, CFO, Swiss
since 2009

Stephan Schindler joined Bachem Holding AG as Chief Financial Officer (CFO) and Member of the Corporate Executive Committee in 2009. He began his business career in informatics. In 1991 he took over his first management position as Head of Informations Center at Patria Insurances in Basel. In parallel he persistently pursued his extra-occupational studies in business economics. Following his successful graduation with an emphasis on finance and control, he joined the Corporate Finance Department at F. Hoffmann-La Roche AG. From 1997 up to his move into the Vitamins Division, he headed the company’s Credit Management and Intercompany Reconciliation Department. In the context of his continued further education, Stephan Schindler will complete an international MBA program Zurich/Boston.

Daniel Erne (1952) Dr. sc. nat. ETH, CTO, Swiss
since 1997

Daniel Erne joined Bachem AG in 1987 as Head Quality Control. Since 1997 he is a Member of the Corporate Executive Committee of the Bachem Group responsible for Quality Assurance and Regulatory Affairs. He received his education as a chemist at the Swiss Federal Institute of Technology in Zurich (ETHZ), then became a research fellow at the University of Utah, Salt Lake City, and at ETHZ before joining Bachem AG. Daniel Erne is member of the Board of Directors of Pevion Biotech AG.

Lester Mills (1958), Ph.D. in chemistry, MBA, CMO, citizen of Great Britain and Switzerland
since 2009

Lester Mills joined Bachem Holding AG as Chief Marketing Officer (CMO) and Member of the Corporate Executive Committee in 2009. He is responsible for all sales and marketing activities of the Bachem Group.
He studied chemistry at Cambridge University (UK) and gained a Ph.D. at the University of East Anglia (UK). Later he received an MBA from the State University of New York, USA (2001). Lester Mills started his career 1987 in R&D with Lonza AG, Visp (CH). Following this he spent several years working in the USA in commercial development for Lonza and later with Genzyme Pharmaceuticals LLC (1996). In 1998 he joined Roche Vitamins AG (later DSM Nutritional Products Europe AG), where he was the Sales Director for Europe until the end of 2008.